Form EFFECT Cidara Therapeutics,

January 12, 2026 11:30 AM UTC
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 9, 2026
Accession Number: 0001193125-26-005766
Submission Type: POS AM
CIK: 0001610618
Company Name: Cidara Therapeutics, Inc.
File Number: 333-284022


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings